Antibody and antibody-dependent cellular cytotoxicity responses against the bamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders

Journal of Infectious Diseases

Volumn 175, Issue 1, 1997, Pages 38-46

  Tanner, J E ^b   Wei, M X ^c   Alfieri, C ^c   Ahmad, A ^c   Taylor, P ^c   Ooka, T ^c   Menezes, J ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; DNA SEQUENCE; EFFECTOR CELL; EPSTEIN BARR VIRUS; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; OPEN READING FRAME; PRIORITY JOURNAL; SEROCONVERSION; TARGET CELL; TRANSCRIPTION REGULATION; VIRUS GENOME; VIRUS INFECTION;

EID: 0031026202     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.1.38     Document Type: Article

References (22)

1. Henle W, Henle G. Epstein-Barr virus and infectious mononucleosis. N Engl J Med 1973;288:263-5.
2. Tanner J, Weis J, Fearon D, Whang Y, Kieff E. Epstein-Barr virus gp350/ 220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 1987;50:203-13.
3. Tsoukas CD, Lambris JD. Expression of CR2/EBV receptors on human thymocytes detected by monoclonals. Eur J Immunol 1988;18:1299-302.
4. Birkenbach M, Tong X, Bradbury LE, Tedder T, Kieff E. Characterization of an Epstein-Barr virus receptor on human epithelial cells. J Exp Med 1992;176:1405-24.
5. Kieff E, Liebowitz D. Epstein-Barr virus and its replication. In: Fields BN, Knipe M, eds. Virology. 2nd ed. New York: Raven Press, 1990:897-928.
6. Khanna R, Burrows SR, Moss DJ. Immune regulation in Esptein-Barr virus-associated diseases. Microbiol Rev 1995;59:387-405.
7. Murray RJ, Kurilla MG, Brooks JM, et al. Identification of target antigens for human cytotoxic T cell response to Epstein-Barr virus: implications for the immune control of EBV-positive malignancies. J Exp Med 1992;176:157-68.
8. Haddad RS, Hutt-Fletcher LM. Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells. J Virol 1989;63:4998-5005.
9. Heinemann T, Gong M, Sample J, Kieff E. Identification of the EpsteinBarr virus gp85 gene. J Virol 1988;62:1101-7.
10. Hoffman GJ, Sondra GL, Hayward SD. Monoclonal against a 250,000dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Proc Natl Acad Sci USA 1980;77:2979-83.
11. Masucci MG, Bejarano MT, Masucci G, Klein E. Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virusinfected B cells. Cell Immunol 1983;76:311-21.
12. Strang G, Rickinson AB. Multiple HLA class I-dependent cytotoxicities constitute the non HLA-restricted response in infectious mononucleosis. Eur J Immunol 1977;17:1007-13.
13. Zinkernagel RM. Immunity to viruses. In: Paul WE, ed. Fundamental immunology. 3rd ed. New York: Raven Press, 1993:1211-50.
14. Wei MX, Ooka TA. Transforming function of the BARF1 gene encoded by Epstein-Barr virus. EMBO J 1989;8:2897-903.
15. Baer R, Bankier AT, Biggin MD, et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984;310:207-11.
16. Raab-Traub N, Hoos R, Yang CS, Henry B II, Pagano J. Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol 1983;48:580-90.
17. Hitt MM, Allday MJ, Hara T, et al. EBV gene expression in NPC-related tumors. EMBO J 1989;8:2639-51.
18. Brooks L, Yao Y, Rickinson AB, Young LS. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: co-expression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992;66:2689-97.
19. Chen HL, Lung M, Jonathan L, et al. Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology 1992;191:193-201.
20. Sadler RH, Raab-Traub N. Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol 1995;69:1132-41.
21. Martel-Renoir D, Grunewald V, Touitou R, Schwaab G, Joab I. Qualitative analysis of the expression of Epstein-Barr virus genes in nasopharyngeal carcinoma biopsies. J Gen Virol 1995;76:1401-8.
22. Wei MX, Moulin JC, Decaussin G, Berger F, Ooka T. Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line. Cancer Res 1994;54:1843-8.